Abstract
The histological breakdown of a consecutive series of 264 surgically resected malignant lesions of the breast was studied. Oestrogen and epidermal growth factor receptor status was quantified and presented along with size and lymph node status of the non-ductal lesions. Those non-ductal tumours containing EGF receptors have all recurred within two years of resection. Twenty-one percent of the lobular carcinomas contained EGF receptors compared to 34% of ductal carcinomas. EGF receptor status appeared to be associated with an increased risk of early recurrence and death whatever the histological sub-type of the breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sainsbury, J., Nicholson, S., Angus, B. et al. Epidermal growth factor receptor status of histological sub-types of breast cancer. Br J Cancer 58, 458–460 (1988). https://doi.org/10.1038/bjc.1988.240
Issue Date:
DOI: https://doi.org/10.1038/bjc.1988.240
This article is cited by
-
Extracellular region of epidermal growth factor receptor: a potential target for anti-EGFR drug discovery
Oncogene (2017)
-
Role of epidermal growth factor receptor in breast cancer
Breast Cancer Research and Treatment (2012)
-
Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma
Multidisciplinary Respiratory Medicine (2010)
-
The role of tyrosine kinase Etk/Bmx in EGF-induced apoptosis of MDA-MB-468 breast cancer cells
Oncogene (2004)
-
Signal transduction in mammary tumorigenesis: a transgenic perspective
Oncogene (2000)